Vimarsana
Biggest News Aggregation in the World

Page 12 - Webcast Today News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Webcast Today. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Webcast Today Today - Breaking & Trending Today

Investegate |Global Blood Therapeutics, Inc Announcements | Global Blood Therapeutics, Inc: GBT Presents Positive New Real-World Evidence Data at EHA2022 Congress Further Supporting Clinical Use of Oxbryta® (voxelotor) in Sickle Cell Disease - Vimarsana News

Investegate |Global Blood Therapeutics, Inc Announcements | Global Blood Therapeutics, Inc: GBT Presents Positive New Real-World Evidence Data at EHA2022 Congress Further Supporting Clinical Use of Oxbryta® (voxelotor) in Sickle Cell Disease

Investegate announcements from Global Blood Therapeutics, Inc, GBT Presents Positive New Real-World Evidence Data at EHA2022 Congress Further Supporting Clinical Use of Oxbryta® (voxelotor) in Sickle Cell Disease

Rigel Announces Top-line Results from FORWARD Phase 3 Clinical Trial of Fostamatinib in Patients with Warm Autoimmune Hemolytic Anemia - Vimarsana News

Rigel Announces Top-line Results from FORWARD Phase 3 Clinical Trial of Fostamatinib in Patients with Warm Autoimmune Hemolytic Anemia

Conference call and webcast to be held today at 8:00 a.m. Eastern TimeSOUTH SAN FRANCISCO, Calif., June 8, 2022 /PRNewswire/ -- Rigel Pharmaceutic...

Ocugen Provides Business Update and First Quarter 2022 Financial Results - Vimarsana News

Ocugen Provides Business Update and First Quarter 2022 Financial Results

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Neurocrine Biosciences Reports First Quarter 2022 Financial Results and Reiterates 2022 Financial Guidance - Vimarsana News

Neurocrine Biosciences Reports First Quarter 2022 Financial Results and Reiterates 2022 Financial Guidance

/PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the first quarter ended March 31, 2022 and reiterated...

Rigel Reports First Quarter 2022 Financial Results and Provides Business Update - Vimarsana News

Rigel Reports First Quarter 2022 Financial Results and Provides Business Update

/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported financial results for the first quarter ended March 31, 2022, including sales of...